1 / 7

Decentralized clinical trials ppt | future of decentralized trials

The Decentralized Clinical trails Goal is to provide a hybrid, flexible system that can promote high patient engagement and patient-centric study. Check out this blog to know, Why decentralized Clinical trials are the way of the future.<br><br><br><br><br><br><br><br><br>

shirley4
Download Presentation

Decentralized clinical trials ppt | future of decentralized trials

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. DECENTRALISATION THE FUTURE OF CLINICAL TRIALS

  2. WHAT MAKES DECENTRALISATION THE FUTURE OF CLINICAL TRIALS? CROs to take the first step toward the future of clinical trials With the emergence of COVID-19, Decentralisation of Clinical Trials became necessary to comply with social distancing requirements while carrying out clinical research. Over the past few years, the clinical trial landscape has shifted its focus to patient-centric practices to promote patient engagement. But now as the pandemic is long gone, it is time to reflect on how DCT studies are genuinely addressing long-standing issues in research and development for sponsors, study teams, and of course, the patients! ClinionAI

  3. WHAT IS A DECENTRALISED CLINICAL TRIAL? Decentralised clinical trials involve a combination of innovative technologies with a patient-centric study design to communicate with study participants and collect data for conducting clinical studies using a hybrid approach The primary goal of DCT is to provide a hybrid, flexible system that can promote high patient engagemen ClinionAI

  4. Traditional trials vs Decentralised trials Site-centred advertising targeting local participants Digital advertising, allowing CROs to reach a diverse patient population. In-person consent, via physical signature E-consent (digital consent signature) form patients located far away from the site In-person physical tests In-person recruitment Tele-consultation and home visits by medical personnel and nursing staff On-site treatment and check up where patients have to visit the site Low – due to scheduled in-person patient visits Virtual recruitment Home healthcare and teleconsultation. Remote monitoring by devices and self- care platforms Delayed – Requires final in- person visits

  5. WHY DECENTRALISED CLINICAL TRIALS ARE THE WAY OF THE FUTURE? With the growing need for accelerated drug development, traditional site- centric clinical trial models have evolved to handle consumer requirements during unforeseen events. According to recent data published by the Globaldata Pharma Intelligence Center, decentralised or remote clinical trials have successfully brought research closer to the patients, with an overall increase of 1.3% of all trials in 2011 to 2.5% in 2020. Allows for a greater geographical reach, which is important for enrolling a diverse group of participants. Eliminates the need for travel, which can be a barrier to participation.

  6. CONTACT CORPORATE To get started with Clinion integrated DCT platform, reach out to our experts! EMAIL ADDRESS PHONE NUMBER WEBSITE sales@clinion.com https://www.clinion.com/ +91 733 738 2327

  7. THANK YOU!! REVOLUTIONISE YOUR CLINICAL TRIAL EXPERIENCE WITH AI-ENABLED AUTOMATION

More Related